NCCN Updates Supportive Care Guidelines for VTE

NCCN recently updated the NCCN Guidelines for Venous Thromboembolic Disease, which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE), and is a common condition in people with cancer. Noted updates include the expanded use of graduated compression stockings in prophylaxis and ...

Urine Test Predicts Vein Clot Risk

... These clots can become dangerous if they travel to the lungs to produce a pulmonary embolism. But the presence of albumin in urine might warn of vte risk, the new study found. "Microalbuminuria is a known risk factor for arterial conditions such as myocardial infarction [heart attack] and stroke...

Journal Chest: April news briefs

...t-procedure venous thromboembolism (VTE) was 0.30 percent. The incidence of vte increased slightly with the presence of risk factors, including prior VTE, ...ent therapy, and obesity. Researchers conclude that the low overall risk of vte in podiatric surgery suggests routine prophylaxis is not warranted. This st...

Video: CRESTOR(R) Reduced Risk of Blood Clots in the Veins

...eca/37394/ Venous thromboembolism, a serious and sometimes fatal condition, occurs when a blood clot forms in a vein. The most common form of vte is deep vein thrombosis (DVT), which occurs in the 'deep veins' usually in the legs or pelvis. An embolism is created if the clot travels through the ...

Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients

...ision Resources' Clinical Gold Standard Status for vte Prophylaxis in 2012, According to a New Report fro...at most influences their prescribing decisions for vte prophylaxis in medically ill patients. Clinical da...ficacy finds that an orally available therapy for vte prophylaxis in medically ill patients would earn a...

Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date

...imary prevention of venous thromboembolism (VTE) Treatment of acute vte Secondary prevention of vte Prevention of cardiac events in patients with acute coronary syndr...

ESC reaffirms advice on cardiovascular risks associated with long-haul flights

...sion stockings is for some travelers an important way of preventing deep venous thrombosis." Studies cited by The Lancet suggest that the risk of vte increases when flight duration exceeds four hours. This raised risk is related to immobility, dehydration, and reduced oxygen in the cabin, as well as...

Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations

...mphasis by the medical insurance industry for hospitals to take measures in vte prevention. The DVTeamCare Hospital Award increases awareness among medica...l professionals of the steps that they can take to reduce the prevalence of vte during and post hospitalization. It recognizes excellence in practice in w...

Cancer Drug Ups Risk of Clots in Veins

...risk for VTE, and benefits/risk should be evaluated in patients who develop vte on Avastin," added study senior author Dr. Shenhong Wu, an assistant profes...a high dose. People with colon cancer had the highest risk of developing vte (19 percent of patients). Almost 15 percent of those with non-small cell lu...

Flu Shots Lower Risk of Blood Clots

... and avoid infection, you're less likely to get clots in the veins and arteries." The authors compared 727 patients with one documented episode of vte (deep vein thrombosis or pulmonary embolism) and no history of cancer within the past five years (cancer is a risk factor for clots) with an equal num...

VTE in Medical Technology

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

WORCESTER, Massachusetts, July 08, 2007 /PRNewswire/ -- - ENDORSE Global Findings Highlight the Need to Urgently Implement Hospital-Wide Strategies to Optimize VTE Management: Systematically Assess Patient Risk for VTE and Provide Appropriate prophylaxis to Prevent VTE Venous thromboembolism (...

CRESTOR(R) Reduced Risk of Blood Clots in the Veins

...of Medicine. Venous thromboembolism, a serious and sometimes fatal condition, occurs when a blood clot forms in a vein. The most common form of vte is deep vein thrombosis (DVT), which occurs in the 'deep veins' usually in the legs or pelvis. An embolism is created if the clot travels through the ...

Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b

...e phase III studies for DU-176b, targeting patients with atrial fibrillation, before the end of 2008. Study Result Details vte incidence (%) Bleeding occurrence*** (%) Dalteparin 43.8 [35.5-52.3]# 0 [0-2.1] DU-176b 15mg 28.2 [21.6-35.6]* ...

ORTHO EVRA(R) Prescribing Information Updated

...ling of risk) in women using ORTHO EVRA compared to women using birth control pills. The previous labeling reported two estimates of relative risk for vte of 0.9 (indicating no increase in risk) and 2.4 (indicating an approximate doubling of risk). This information is presented in a table in the WARNINGS...

Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study

...abigatran etexilate is an investigational compound. It has been submitted to European authorities for approval in a first intended indication; primary vte prevention following elective total hip or knee replacement surgery. The safety and efficacy of dabigatran etexilate has not been evaluated by the U.S...

Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)

...otal hospital direct medical costs associated with vte treatment are reduced by $550 per patient when the...ess likely to be readmitted to the hospital with a vte recurrence within 90 days. The findings were prese...l costs and VTE-related readmission rates of these vte treatment regimens are not clear. A retrospectiv...

The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke

...nced the publication of the PREVAIL (Prevention of vte after Acute Ischemic Stroke with LMWH Enoxaparin) ...in (UFH) 5000 IU twice a day for the prevention of vte in patients who suffered an acute ischemic stroke,...e at an increased risk for developing VTE. Without vte prophylaxis, up to 75% of patients with hemiplegia...

Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting

... (RRMM) -- P. Sonneveld; Abstract #8023; June 3, 2007; 3:00-3:15pm; McCormick Place Convention Center, E354b An analysis of erythropoietin (EPO) and vte in MM patients treated with anthracycline-based chemotherapy and the immunomodulatory agent thalidomide -- R. Baz; Abstract #8107; June 2, 2007; 8:00a...

Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75

...alidomide Pharmion as a first line therapy for multiple myeloma in Europe. Data Presented Saturday, June 2 An analysis of erythropoietin (EPO) and vte in MM patients treated with anthracycline-based chemotherapy and the immunomodulatory agent thalidomide -- R. Baz; Abstract #8107; June 2, 2007; 8:00a...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...2% reduction of risk (p=0.01) for developing major vte (the composite of proximal DVT, non-fatal PE and V...ion has demonstrated better efficacy in preventing vte than the current standard of care, while also disp...g enoxaparin (RRR 49%; p less than 0.001). Major vte (the composite of proximal DVT, non-fatal PE and V...

VTE in Medical Dictionary

Thromboembolism

... Thromboembolism ... Learn about the impact of venous thromboembolism (VTE); deep vein thrombosis (DVT) and pulmonary embolism (PE), vte risk after hip or knee surgery, and thrombosis ... Freedom from thromboembolism was 91% (95% CI = 77% to 98%) at 20 years. ... of 256 hos...

Knee arthroscopy

... a required part of any knee arthroscopy is the posteromedial drive thru; ... patients undergoing knee arthroscopy have a moderate risk of vte and effective ... Arthroscopy is a surgical procedure that allows your doctor to look at the inside of a joint in your body through ... See a ...

VTE in Biological Technology

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

WORCESTER, Massachusetts, February 1 /PRNewswire/ -- - ENDORSE Global Findings Highlight the Need to Urgently Implement Hospital-Wide Strategies to Optimize VTE Management: Systematically Assess Patient Risk for VTE and Provide Appropriate Prophylaxis to Prevent VTE ENDORSE multinational s...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay

...e ACL TOP(R) Hemostasis Testing System and 100% for DVT and 99.1% for PE on the ACL ELITE(R) system. In 2007, the FDA granted clearance for the same vte exclusionary claims with IL's second-generation HemosIL D-Dimer HS assay. Both assays now have proven clinical performance for the exclusion of DVT an...

Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT

...py alone for the treatment of DVT. For complete information on the new ACCP vte Guidelines, visit http://www.TheNewGuidelines.org . While anticoagulatio...http://www.bacchusvascular.com . For complete information on the new ACCP vte Guidelines, visit: http://www.TheNewGuidelines.org . ...

Clexane(R)/Lovenox(R) Approved in Japan

...nd pulmonary embolism are common manifestations of vte and can significantly impact morbidity and mortality in surgical patients. The Japanese vte guidelines state that, without prophylaxis, betwee... The total annual burden of non-fatal symptomatic vte in the European Union, which included DVT and PE, ...

ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting

...epresents a major health issue, with an incidence of 1 to 3 per 1000 individuals per year and a high early mortality rate. One of the risk factors for vte is major orthopaedic surgery. Anticoagulation prophylaxis is therefore indicated in this setting. In addition, in patients who develop a VTE, anticoag...

ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402

...epresents a major health issue, with an incidence of 1 to 3 per 1000 individuals per year and a high early mortality rate. One of the risk factors for vte is major orthopaedic surgery. Anticoagulation prophylaxis is therefore indicated in this setting. In addition, in patients who develop a VTE, anticoag...